Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SkinMedica is a premier professional skincare company that specializes in the development of advanced aesthetic products based on regenerative medicine principles. Founded by renowned dermatologists, the company is best known for its proprietary Tissue Nutrient Solution (TNS) technology, which utilizes a high concentration of naturally occurring growth factors, cytokines, and soluble proteins to promote skin repair and rejuvenation. SkinMedica's portfolio includes a wide range of clinically-proven products targeting skin aging, hyperpigmentation, and texture, primarily distributed through medical professionals. Since its acquisition by Allergan (now part of AbbVie), the company has continued to lead the physician-dispensed skincare market by integrating pharmaceutical-grade research with aesthetic science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skinmed.